Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Milrinone vs dobutamine for pulmonary hypertension
IRCT20211102052941N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of milrinone and dobutamine in pulmonary hypertension (PH) (2 arms), sponsored by Isfahan University of Medical Sciences. Started Jan 2022; status: completed.
02
Drugs
milrinonedobutamine
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on IRCT20211102052941N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211102052941N1.